Virginia Retirement Systems ET AL decreased its position in HealthSouth Corp (NYSE:HLS) by 69.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,500 shares of the company’s stock after selling 14,700 shares during the period. Virginia Retirement Systems ET AL’s holdings in HealthSouth were worth $301,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in HLS. Aperio Group LLC boosted its holdings in shares of HealthSouth by 7.6% in the second quarter. Aperio Group LLC now owns 21,165 shares of the company’s stock valued at $1,024,000 after purchasing an additional 1,496 shares during the period. Strs Ohio boosted its holdings in shares of HealthSouth by 7.5% in the second quarter. Strs Ohio now owns 14,300 shares of the company’s stock valued at $692,000 after purchasing an additional 1,000 shares during the period. NGAM Advisors L.P. boosted its holdings in shares of HealthSouth by 1.4% in the second quarter. NGAM Advisors L.P. now owns 10,448 shares of the company’s stock valued at $506,000 after purchasing an additional 142 shares during the period. Great West Life Assurance Co. Can boosted its holdings in shares of HealthSouth by 3.1% in the second quarter. Great West Life Assurance Co. Can now owns 53,265 shares of the company’s stock valued at $2,577,000 after purchasing an additional 1,602 shares during the period. Finally, World Asset Management Inc boosted its holdings in shares of HealthSouth by 3.9% in the second quarter. World Asset Management Inc now owns 5,702 shares of the company’s stock valued at $276,000 after purchasing an additional 215 shares during the period. Hedge funds and other institutional investors own 93.37% of the company’s stock.
A number of analysts have weighed in on the company. Royal Bank of Canada restated a “buy” rating on shares of HealthSouth in a report on Wednesday, November 15th. William Blair restated an “outperform” rating on shares of HealthSouth in a report on Tuesday, November 21st. Robert W. Baird restated a “buy” rating and set a $55.00 target price on shares of HealthSouth in a report on Monday, October 9th. Mizuho upgraded HealthSouth from a “neutral” rating to a “buy” rating and set a $55.00 target price for the company in a report on Thursday, November 2nd. Finally, Zacks Investment Research lowered HealthSouth from a “buy” rating to a “hold” rating in a report on Tuesday, October 31st. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the stock. HealthSouth presently has a consensus rating of “Hold” and a consensus target price of $51.75.
HealthSouth (NYSE:HLS) last issued its quarterly earnings results on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. The business had revenue of $995.60 million for the quarter, compared to the consensus estimate of $985.75 million. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.65 earnings per share. sell-side analysts forecast that HealthSouth Corp will post 2.72 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date of this dividend is Friday, December 29th. HealthSouth’s payout ratio is presently 36.36%.
In other HealthSouth news, Director Yvonne M. Curl purchased 1,000 shares of HealthSouth stock in a transaction dated Wednesday, November 1st. The shares were acquired at an average cost of $45.95 per share, with a total value of $45,950.00. Following the completion of the transaction, the director now owns 64,144 shares in the company, valued at approximately $2,947,416.80. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.60% of the company’s stock.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).
Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with MarketBeat.com's FREE daily email newsletter.